← All trials
NCT01471119
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2011
- Primary completion
- Jun 1, 2015
- Completion date
- Jun 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 240
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Zhejiang UniversityLead sponsor
- Zhejiang UniversityOverall official - principal investigator
- Fudan UniversityCollaborator
- Peking UniversityCollaborator
- Zhejiang Wolwo Bio-pharmaceutical Co. LTD.Collaborator
- Soochow UniversityCollaborator
- Zhejiang UniversityReponsible party - principal investigator
- Jiao Tong UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.